Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Equity (2021 - 2025)

Lucid Diagnostics' Return on Equity history spans 5 years, with the latest figure at 3.16% for Q4 2025.

  • For Q4 2025, Return on Equity rose 461.0% year-over-year to 3.16%; the TTM value through Dec 2025 reached 3.16%, up 461.0%, while the annual FY2025 figure was 7.11%, 2246.0% up from the prior year.
  • Return on Equity reached 3.16% in Q4 2025 per LUCD's latest filing, roughly flat from 3.16% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.73% in Q1 2022 to a low of 8832.14% in Q1 2025.
  • Average Return on Equity over 5 years is 550.42%, with a median of 3.16% recorded in 2025.
  • Peak YoY movement for Return on Equity: surged 42216bps in 2024, then crashed -882233bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 1.83% in 2021, then decreased by -21bps to 2.22% in 2022, then tumbled by -19257bps to 429.93% in 2023, then skyrocketed by 98bps to 7.76% in 2024, then surged by 59bps to 3.16% in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Return on Equity are 3.16% (Q4 2025), 3.16% (Q3 2025), and 44.47% (Q2 2025).